Prothena (Nasdaq:PRTA) is a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.
http://www.prothena.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.1 seconds
Prothena Corporation plc
Domain Admin
25-28 N●●●●●●●ll Quay
Du●●in , 1
IE
View this contact
Safenames Ltd
International Domain Administrator
Safenames H●●●●●●●●●●●ise Parkway
Milt●●●●ynes , Bucks, MK14 6LS
UK
View this contact
International Domain Tech
International Domain Tech
Safenames H●●●●●●●●●●●ise Parkway
Milt●●●●ynes , Bucks, MK14 6LS
UK
View this contact
BUY YOUR DOMAIN
11
YEARS
7
MONTHS
0
DAYS
SAFENAMES LTD
WHOIS : whois.safenames.net
REFERRED : http://www.safenames.net
PAGES IN
THIS WEBSITE
13
SSL
EXTERNAL LINKS
68
SITE IP
198.58.107.223
LOAD TIME
0.103 sec
SCORE
6.2
Prothena Corporation | Harnessing the Power of the immune system to fight progressive disease | prothena.com Reviews
https://prothena.com
Prothena (Nasdaq:PRTA) is a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.
Prothena Culture and Values
Visit us on LinkedIn! At Prothena, our success is driven by our employees. We are dedicated to finding the best and brightest talent who live by the same vision that improving human health requires a workforce that puts patients first and is willing to be bold by trying new ideas that will result in innovative therapies. It's not just about. We do at Prothena, it's. We have a culture that fosters creativity, because we understand that being creative. Prothena employees must also be courageous. Prothena i...
Investor Relations - Prothena Corporation plc
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Day High: 62.47. Day Low: 58.95. Aug 17, 2015. Delayed 20 min., by eSignal. Aug 4, 2015. Prothena Reports Second Quarter 2015 Financial Results and Provides R&D Update. Jun 29, 2015. Prothena Announces Addition of Seasoned Executive to Board of Directors. View all press releases ». 124; Privacy Policy.
prothena.com
PRX003 for Psoriasis and Other Inflammatory Diseases - Prothena Corporation
http://www.prothena.com/pipeline/prx003-for-psoriasis-and-other-inflammatory-diseases
NEOD001 for AL Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Psoriasis and Other Inflammatory Diseases. Events & Presentations. Financials & Filings. NEOD001 for AL Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Psoriasis and Other Inflammatory Diseases. Our Phase 3 VITAL Study website is now online. PRX003 for Psoriasis and Other Inflammatory Diseases. Anti-MCAM antibodies also may be useful for treating metastatic cancers, including melanoma. Prothena has generated a portfolio of mon...
Management Team - Prothena Corporation
http://www.prothena.com/company/management-team
NEOD001 for AL Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Psoriasis and Other Inflammatory Diseases. Events & Presentations. Financials & Filings. Our Phase 3 VITAL Study website is now online. Dale B. Schenk, PhD. President and Chief Executive Officer, Director. A W (Bill) Homan. Mr Homan has served as our Chief Legal Officer since 2014. Prior to joining Prothena, he was Senior Vice President, General Counsel and Secretary of Complete Genomics, Inc., a position he held from 2012 unt...Mr Ho...
Untitled Document
http://www.prothena.com/video/neod001.htm
PRX002 for Parkinson’s disease and other related synucleinopathies - Prothena Corporation
http://www.prothena.com/pipeline/prx002-for-parkinsons-disease
NEOD001 for AL Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Psoriasis and Other Inflammatory Diseases. Events & Presentations. Financials & Filings. NEOD001 for AL Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Psoriasis and Other Inflammatory Diseases. Our Phase 3 VITAL Study website is now online. PRX002 for Parkinson’s disease and other related synucleinopathies. Prothena’s scientists have generated monoclonal antibodies targeting α-synuclein. We have designed these antibodies ...
Science - Prothena Corporation
http://www.prothena.com/science
NEOD001 for AL Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Psoriasis and Other Inflammatory Diseases. Events & Presentations. Financials & Filings. Prothena Corporation plc (Nasdaq: PRTA) is targeting proteins with its novel immunotherapy programs to transform patients’ lives. These same scientists also pioneered significant scientific discoveries with cell adhesion molecules, leading to the discovery, development and commercialization of Tysabri. The global Phase 3 registrational trial, The ...
TOTAL PAGES IN THIS WEBSITE
13
Analyst Coverage - Prothena Corporation plc
http://ir.prothena.com/analysts.cfm
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Prothena Corporation plc is covered by the following analysts. Bank of America Merrill Lynch. Geoff Meacham, Ph.D. Kennen MacKay, Ph.D. Jerry Isaacson, Ph.D. Heather Behanna, Ph.D. 2016 Prothena Corporation plc | Terms and Conditions. 124; Privacy Policy.
Investor Relations - Prothena Corporation plc
http://ir.prothena.com/index.cfm
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Aug 31, 2016. Delayed 20 min., by eSignal. Aug 30, 2016. Prothena to Participate in Upcoming September Investor Conferences. Aug 2, 2016. Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update. View all press releases ». 2016 Prothena Corporation plc | Terms and Conditions. 124; Privacy Policy.
Press Releases - Prothena Corporation plc
http://ir.prothena.com/releases.cfm
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Aug 30, 2016. Prothena to Participate in Upcoming September Investor Conferences. Aug 2, 2016. Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update. Jul 6, 2016. Prothena to Participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference. DUBLIN, Ireland, July 06, 2016 (GLOBE NEWSWIRE) - P...
Events & Presentations - Prothena Corporation plc
http://ir.prothena.com/events.cfm
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Sep 7, 2016. Credit Suisse Antibody Day. Credit Suisse Antibody Day. Please sign up for email alert notification. Sep 8, 2016. Citi's 11th Annual Biotech Conference. Citi's 11th Annual Biotech Conference. Please sign up for email alert notification. Sep 12, 2016. Morgan Stanley Global Healthcare Conference. POSTER: ...
Financials & Filings - Prothena Corporation plc
http://ir.prothena.com/financials.cfm
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Third Quarter 2016 Financial Results. Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update. Apr 4, 2016. Apr 2, 2015. Feb 25, 2016. Mar 13, 2015. Nov 2, 2016. Aug 2, 2016. Add PDF file to Briefcase. 2016 Prothena Corporation plc | Terms and Conditions. 124; Privacy Policy.
Historic Stock Lookup - Prothena Corporation plc
http://ir.prothena.com/stocklookup.cfm
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Adjusted historic prices for the week of November 7, 2016. Nov 7, 2016. Year End Stock Prices. 2016 Prothena Corporation plc | Terms and Conditions. 124; Privacy Policy.
Email Alert Subscription - Prothena Corporation plc
http://ir.prothena.com/profile.cfm
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Step 1 of 3: Select Options. Quarterly and Annual Reports. All Events and Presentations. In advance of any event. Send me the closing stock price. Send me a stock update at the end of the week. Alert me when the stock crosses the following price thresholds:. Current price: 47.55. 124; Privacy Policy.
TOTAL LINKS TO THIS WEBSITE
68
Prothemestartathemes.com
This Domain Name Has Expired - Renewal Instructions.
Landing Page | Prothemeus.com | Innovative WordPress Themes
We are currently rebuilding our official website and support system. If you would like to be notified of new updates, please subscribe to the newsletter below or follow us through Facebook. We’ll be up and running in no time!
STRATO
Página Não Encontrada
prothemovie.com - This website is for sale! - prothemovie Resources and Information.
The owner of prothemovie.com. Is offering it for sale for an asking price of 677 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
Prothena Corporation | Harnessing the Power of the immune system to fight progressive disease
NEOD001 for AL Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Psoriasis and Other Inflammatory Diseases. Events & Presentations. Financials & Filings. Prothena Corporation plc is a late-stage clinical. Biotechnology company focused on the discovery,. Development and commercialization of novel. Protein immunotherapy programs for the. Potential treatment of diseases that. Involve amyloid or cell adhesion. Our Phase 3 VITAL Study website is now online. Potential Mechanism of Action (MOA) Videos:.
My Site
This is my site description. Powered by InstantPage® from GoDaddy.com. Want one?
Prothenberger.com
Still wrapping my head around everything. Friday – A couple days late. Thursday – I’m living my dream. Wednesday – I did the Carlton in Nicaragua…. On Thursday – I’m living my dream. On Wednesday – I did the Carlton in Nicaragua…. On First day of School – English School. On First day of School – English School. Still wrapping my head around everything. In closing, I’d like to invite anyone reading to check out two things:. First our partners for the week http:/ www.highlandsmission.com. January 29, 2015.
HostGator - Please Configure Your Name Servers
Click Here for 24/7/365 Live Chat! Please configure your name servers. You're seeing this page because your domain is setup with the default name servers: ns1.hostgator.com. And ns2.hostgator.com. In order to point the domain to your server, please login here. To manage your domain's settings. You can find the name servers you need to use in your welcome email or HostGator control panel. For more information, please see this page. How can I avoid this in the future? How do I change my name servers?
Gospelfacilitairbedrijf Protheo-Sound
2014 -TED camporee te Ommen, 2500 jongden die zingen, drama kijken en luisteren naar Jonatan Tejel, Associate Youth Director (Internationale jeugdleider van de Adventkerk). Protheo-Sound deed geluid en licht. Wat in de jaren 80 begon als een opname van preken en distributie aan kerkgangers die niet naar de dienst konden komen is uitgegroeid tot een serieus gospelfacilitairbedrijf. We werken met digitale geluidsregie van Roland en datavideo / Roland videoregistratie. We werken samen met:.
